Physiol. Genomics Ad Instruments
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
QUICK SEARCH:   [advanced]


     

Physiol. Genomics (September 11, 2002). doi:10.1152/physiolgenomics.00008.2002
This Article
Right arrow Full Text (PDF)
Right arrow All Versions of this Article:
11/2/81    most recent
00008.2002v1
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Lankford, A. R
Right arrow Articles by Matherne, G. P.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Lankford, A. R
Right arrow Articles by Matherne, G. P.

Articles in PresS, published online ahead of print September 11, 2002
Physiol Genomics, 10.1152/physiolgenomics.00008.2002
Submitted on January 29, 2002
Accepted on September 9, 2002

Gene Expression Profile of Mouse Myocardium with Transgenic Overexpression of A1 Adenosine Receptors

Amy R Lankford1*, Anne M Byford1, Kevin J Ashton2, Brent A French3, Jae K Lee4, John P Headrick4, and G. Paul Matherne1

1 Department of Pediatrics and Cardiovascular Research Center, University of Virginia Health System, Charlottesville, VA, USA
2 Heart Foundation Research Centre, Griffith University Gold Coast Campus, Southport, Queensland, Australia
3 Department of Biomedical Engineering, University of Virginia Health System, Charlottesville, VA, USA
4 Health Evaluation Sciences, University of Virginia Health System, Charlottesville, VA, USA

* To whom correspondence should be addressed. E-mail: arl2b{at}virginia.edu.

Transgenic mice with cardiac-specific overexpression of adenosine A1 receptors have demonstrated metabolic and functional tolerance to myocardial ischemia. We utilized cDNA microarrays to test the hypothesis that the cardioprotective mechanism(s) of A1 overexpression involve(s) altered gene expression. Total RNA extracted from the left ventricles from A1 transgenic (n=4) and wild-type (n=6) mice was hybridized to Affymetrix murine U74A chips. Comparison of RNA expression levels in transgenic to wild-type myocardium revealed approximately 636 known genes with expression significantly altered by greater than 25%. We observed increased expressions of genes including NADH dehydrogenase, the GLUT4 glucose transporter, Na/K ATPase, sarcolemmal KATP channels, and Bcl-xl in A1 receptor overexpressing hearts. We also observed decreased expression of pro-apoptotic genes including a 50% reduction in message level of caspase-8. Protein expression of GLUT4 and caspase-8 was also altered comparable to the differences in gene expression. These data illustrate genes with chronically altered patterns of expression in A1 transgenic mouse myocardium that may be related to adenosine receptor overexpression-mediated cardioprotection.




This article has been cited by other articles:


Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
J. P. Headrick, B. Hack, and K. J. Ashton
Acute adenosinergic cardioprotection in ischemic-reperfused hearts
Am J Physiol Heart Circ Physiol, November 1, 2003; 285(5): H1797 - H1818.
[Abstract] [Full Text] [PDF]

Home page
 Am. J. Physiol. Heart Circ. Physiol.Home page
S. E. Regan, M. Broad, A. M. Byford, A. R. Lankford, R. J. Cerniway, M. W. Mayo, and G. P. Matherne
A1 adenosine receptor overexpression attenuates ischemia-reperfusion-induced apoptosis and caspase 3 activity
Am J Physiol Heart Circ Physiol, March 1, 2003; 284(3): H859 - H866.
[Abstract] [Full Text] [PDF]


HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH
Visit Other APS Journals Online
Copyright © 2002 by the American Physiological Society.